Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Dec 25, 2012 11:49am
235 Views
Post# 20771152

RE: What is up With BRD? - GF/SAS Closeology

RE: What is up With BRD? - GF/SAS Closeology

 

RE:"  that's the best map I've seen of how close SAS Hislop North is to the GF zone!!"

 

[S] Using the scale on pg 8, hole H12 - 029 is a mere 125 m from the BRD boundary, makes an interesting dilema (good problem to have) re party walls, benches, PPV of blasts, etc, but SPECULATION is only that.

 

Alternatively, BRD could always look at mining to the North and put the "squeeze" to SAS. With a JV SAS West or East Pit could be used to collar a decline/ramp to underground at GF. Leaving the option of the GF open pit(s) in-tact. Giving two production sources, with the ramp option being potentially easier (less regulatory intensive ... re timeline to a second stream of diluted UG 6 gpt ore).

 

BWDIK?  The more I look at it, the more I'm convinced that patience COULD be rewarded; provided that the T1, T2 or T3 with deep pockets (enough to obviate a SRP) can wait for the BFS/FFS.

Bullboard Posts